Meningococcal Infections Vaccine Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Meningococcal Infections Vaccine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Quadrivalent (Serogroups A, C, W-135, and Y)
1.2.3 Bivalent (Serogroups C and Y)
1.2.4 Serogroup A
1.2.5 Serogroup B
1.2.6 Serogroup X
1.3 Market by Application
1.3.1 Global Meningococcal Infections Vaccine Market Share by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Meningococcal Infections Vaccine Market Perspective (2018-2029)
2.2 Meningococcal Infections Vaccine Growth Trends by Region
2.2.1 Meningococcal Infections Vaccine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Meningococcal Infections Vaccine Historic Market Size by Region (2018-2023)
2.2.3 Meningococcal Infections Vaccine Forecasted Market Size by Region (2024-2029)
2.3 Meningococcal Infections Vaccine Market Dynamics
2.3.1 Meningococcal Infections Vaccine Industry Trends
2.3.2 Meningococcal Infections Vaccine Market Drivers
2.3.3 Meningococcal Infections Vaccine Market Challenges
2.3.4 Meningococcal Infections Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Meningococcal Infections Vaccine Players by Revenue
3.1.1 Global Top Meningococcal Infections Vaccine Players by Revenue (2018-2023)
3.1.2 Global Meningococcal Infections Vaccine Revenue Market Share by Players (2018-2023)
3.2 Global Meningococcal Infections Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Meningococcal Infections Vaccine Revenue
3.4 Global Meningococcal Infections Vaccine Market Concentration Ratio
3.4.1 Global Meningococcal Infections Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Meningococcal Infections Vaccine Revenue in 2022
3.5 Meningococcal Infections Vaccine Key Players Head office and Area Served
3.6 Key Players Meningococcal Infections Vaccine Product Solution and Service
3.7 Date of Enter into Meningococcal Infections Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Meningococcal Infections Vaccine Breakdown Data by Type
4.1 Global Meningococcal Infections Vaccine Historic Market Size by Type (2018-2023)
4.2 Global Meningococcal Infections Vaccine Forecasted Market Size by Type (2024-2029)
5 Meningococcal Infections Vaccine Breakdown Data by Application
5.1 Global Meningococcal Infections Vaccine Historic Market Size by Application (2018-2023)
5.2 Global Meningococcal Infections Vaccine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Meningococcal Infections Vaccine Market Size (2018-2029)
6.2 North America Meningococcal Infections Vaccine Market Size by Country (2018-2023)
6.3 North America Meningococcal Infections Vaccine Market Size by Country (2024-2029)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Meningococcal Infections Vaccine Market Size (2018-2029)
7.2 Europe Meningococcal Infections Vaccine Market Size by Country (2018-2023)
7.3 Europe Meningococcal Infections Vaccine Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Meningococcal Infections Vaccine Market Size (2018-2029)
8.2 Asia-Pacific Meningococcal Infections Vaccine Market Size by Country (2018-2023)
8.3 Asia-Pacific Meningococcal Infections Vaccine Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Meningococcal Infections Vaccine Market Size (2018-2029)
9.2 Latin America Meningococcal Infections Vaccine Market Size by Country (2018-2023)
9.3 Latin America Meningococcal Infections Vaccine Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Meningococcal Infections Vaccine Market Size (2018-2029)
10.2 Middle East & Africa Meningococcal Infections Vaccine Market Size by Country (2018-2023)
10.3 Middle East & Africa Meningococcal Infections Vaccine Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Creative Biolabs(USA)
11.1.1 Creative Biolabs(USA) Company Detail
11.1.2 Creative Biolabs(USA) Business Overview
11.1.3 Creative Biolabs(USA) Meningococcal Infections Vaccine Introduction
11.1.4 Creative Biolabs(USA) Revenue in Meningococcal Infections Vaccine Business (2018-2023)
11.1.5 Creative Biolabs(USA) Recent Development
11.2 SERUM INSTITUTE OF INDIA PVT.LTD.(India)
11.2.1 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Company Detail
11.2.2 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Business Overview
11.2.3 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Meningococcal Infections Vaccine Introduction
11.2.4 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Revenue in Meningococcal Infections Vaccine Business (2018-2023)
11.2.5 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Meningococcal Infections Vaccine Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Quadrivalent (Serogroups A, C, W-135, and Y)
Table 3. Key Players of Bivalent (Serogroups C and Y)
Table 4. Key Players of Serogroup A
Table 5. Key Players of Serogroup B
Table 6. Key Players of Serogroup X
Table 7. Global Meningococcal Infections Vaccine Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Meningococcal Infections Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Meningococcal Infections Vaccine Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Meningococcal Infections Vaccine Market Share by Region (2018-2023)
Table 11. Global Meningococcal Infections Vaccine Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Meningococcal Infections Vaccine Market Share by Region (2024-2029)
Table 13. Meningococcal Infections Vaccine Market Trends
Table 14. Meningococcal Infections Vaccine Market Drivers
Table 15. Meningococcal Infections Vaccine Market Challenges
Table 16. Meningococcal Infections Vaccine Market Restraints
Table 17. Global Meningococcal Infections Vaccine Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Meningococcal Infections Vaccine Market Share by Players (2018-2023)
Table 19. Global Top Meningococcal Infections Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Infections Vaccine as of 2022)
Table 20. Ranking of Global Top Meningococcal Infections Vaccine Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Meningococcal Infections Vaccine Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Meningococcal Infections Vaccine Product Solution and Service
Table 24. Date of Enter into Meningococcal Infections Vaccine Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Meningococcal Infections Vaccine Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Meningococcal Infections Vaccine Revenue Market Share by Type (2018-2023)
Table 28. Global Meningococcal Infections Vaccine Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Meningococcal Infections Vaccine Revenue Market Share by Type (2024-2029)
Table 30. Global Meningococcal Infections Vaccine Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Meningococcal Infections Vaccine Revenue Market Share by Application (2018-2023)
Table 32. Global Meningococcal Infections Vaccine Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Meningococcal Infections Vaccine Revenue Market Share by Application (2024-2029)
Table 34. North America Meningococcal Infections Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Meningococcal Infections Vaccine Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Meningococcal Infections Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Meningococcal Infections Vaccine Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Meningococcal Infections Vaccine Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Meningococcal Infections Vaccine Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Meningococcal Infections Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Meningococcal Infections Vaccine Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Meningococcal Infections Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 43. Middle East & Africa Meningococcal Infections Vaccine Market Size by Country (2024-2029) & (US$ Million)
Table 44. Creative Biolabs(USA) Company Detail
Table 45. Creative Biolabs(USA) Business Overview
Table 46. Creative Biolabs(USA) Meningococcal Infections Vaccine Product
Table 47. Creative Biolabs(USA) Revenue in Meningococcal Infections Vaccine Business (2018-2023) & (US$ Million)
Table 48. Creative Biolabs(USA) Recent Development
Table 49. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Company Detail
Table 50. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Business Overview
Table 51. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Meningococcal Infections Vaccine Product
Table 52. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Revenue in Meningococcal Infections Vaccine Business (2018-2023) & (US$ Million)
Table 53. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Recent Development
Table 54. Research Programs/Design for This Report
Table 55. Key Data Information from Secondary Sources
Table 56. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Meningococcal Infections Vaccine Market Share by Type: 2022 VS 2029
Figure 2. Quadrivalent (Serogroups A, C, W-135, and Y) Features
Figure 3. Bivalent (Serogroups C and Y) Features
Figure 4. Serogroup A Features
Figure 5. Serogroup B Features
Figure 6. Serogroup X Features
Figure 7. Global Meningococcal Infections Vaccine Market Share by Application in 2022 & 2029
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Meningococcal Infections Vaccine Report Years Considered
Figure 11. Global Meningococcal Infections Vaccine Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Meningococcal Infections Vaccine Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Meningococcal Infections Vaccine Market Share by Region: 2022 VS 2029
Figure 14. Global Meningococcal Infections Vaccine Market Share by Players in 2022
Figure 15. Global Top Meningococcal Infections Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Infections Vaccine as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Meningococcal Infections Vaccine Revenue in 2022
Figure 17. North America Meningococcal Infections Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Meningococcal Infections Vaccine Market Share by Country (2018-2029)
Figure 19. United States Meningococcal Infections Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Meningococcal Infections Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Meningococcal Infections Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Meningococcal Infections Vaccine Market Share by Country (2018-2029)
Figure 23. Germany Meningococcal Infections Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Meningococcal Infections Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Meningococcal Infections Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Meningococcal Infections Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Meningococcal Infections Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Meningococcal Infections Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Meningococcal Infections Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Meningococcal Infections Vaccine Market Share by Region (2018-2029)
Figure 31. China Meningococcal Infections Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Meningococcal Infections Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Meningococcal Infections Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Meningococcal Infections Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Meningococcal Infections Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Meningococcal Infections Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Meningococcal Infections Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Meningococcal Infections Vaccine Market Share by Country (2018-2029)
Figure 39. Mexico Meningococcal Infections Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Meningococcal Infections Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Meningococcal Infections Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Meningococcal Infections Vaccine Market Share by Country (2018-2029)
Figure 43. Turkey Meningococcal Infections Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Meningococcal Infections Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Creative Biolabs(USA) Revenue Growth Rate in Meningococcal Infections Vaccine Business (2018-2023)
Figure 46. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Revenue Growth Rate in Meningococcal Infections Vaccine Business (2018-2023)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Industry Market Size
